In a potential leap forward in the global fight against the pandemic, drugmaker Merck said Friday that its experimental pill for people sick with COVID-19 reduced hospitalizations and deaths by half. If cleared by regulators, it would be the first…
Read More
Antibody drug cuts deaths for some severe COVID patients: study
A cocktail of synthetic antibodies reduces deaths among severe COVID patients who are unable to mount a strong immune response, results from a major clinical trial showed Wednesday. The therapy, developed by the US biotech firm Regeneron and given to…
Read More
US traffic deaths spike even as pandemic cuts miles traveled
Pandemic lockdowns and stay-at-home orders kept many drivers off U.S. roads and highways last year. But those who did venture out found open lanes that only invited reckless driving, leading to a sharp increase in traffic-crash deaths across the country….
Read More
USPS Cuts Could Pose Harm If Mail-Order Meds Delayed: Study
WEDNESDAY, Dec. 16, 2020 (HealthDay)– Delayed mail delivery due to a push from the White House and others to slash spending and services could have enormous consequences for Americans who depend on the U.S. Postal Service for access to urgently…
Read More
A novel monoclonal antibody therapy cuts LDL cholesterol by half in a high-risk patient population
The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol—the so-called “bad” cholesterol—by 50 percent in patients with severe hypercholesterolemia whose condition is resistant to standard treatments, a phase 2 study from the Icahn School of Medicine of Mount Sinai and…
Read More